Felbamate as an oral add-on therapy in six dogs with presumptive idiopathic epilepsy and generalized seizures resistant to drug therapy

BACKGROUND: Idiopathic or genetic epilepsy commonly affects dogs; affected dogs are often refractory to anti-seizure drug therapy. Felbamate is an anti-seizure drug with established pharmacokinetic and safety data for dogs, but little published evidence of efficacy for managing generalized seizures...

Descripción completa

Detalles Bibliográficos
Autores principales: Dewey, Curtis Wells, Rishniw, Mark, Sakovitch, Kasie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculty of Veterinary Medicine 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473368/
https://www.ncbi.nlm.nih.gov/pubmed/36118733
http://dx.doi.org/10.5455/OVJ.2022.v12.i4.5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473368/
https://www.ncbi.nlm.nih.gov/pubmed/36118733
http://dx.doi.org/10.5455/OVJ.2022.v12.i4.5

Ejemplares similares